Literature DB >> 6168354

Tumor markers of pancreatic carcinoma.

J V Klavins.   

Abstract

There is no well-defined specific tumor marker for carcinoma of the pancreas. Carcinoembryonic antigen (CEA) and alphafetal protein (AFP) are produced by some pancreatic cancer cells. A pancreatic oncofetal antigen (POA) cross-reacts with other malignant neoplasms and is not produced by all pancreatic carcinomas. An ammonium sulfate fraction (0-25%) from an aqueous extract of pancreatic carcinoma tissues contains an antigen cross-reacting with extracts of other pancreatic carcinomas and various carcinomas representing all three germinal layers. A heterologous antiserum to this antigen cross-reacts with sera from patients with pancreatic carcinomas in a dilution of 1:16,000. At lower dilutions this antiserum reacts with sera from patients with other carcinomas and with sera from some apparently healthy individuals.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6168354     DOI: 10.1002/1097-0142(19810315)47:6+<1597::aid-cncr2820471423>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Unbiased discovery of interactions at a control locus driving expression of the cancer-specific therapeutic and diagnostic target, mesothelin.

Authors:  Yunzhao R Ren; Raghothama Chaerkady; Shaohui Hu; Jun Wan; Jiang Qian; Heng Zhu; Akhilesh Pandey; Scott E Kern
Journal:  J Proteome Res       Date:  2012-10-12       Impact factor: 4.466

2.  Preoperative and operative diagnosis of pancreatic cancer.

Authors:  I Ihse; G Isaksson
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

3.  Signet ring carcinoma of the pancreas, a rare variant with very high CEA values. Immunohistologic comparison with adenocarcinoma.

Authors:  K J Tracey; M J O'Brien; L F Williams; M Klibaner; P K George; C A Saravis; N Zamcheck
Journal:  Dig Dis Sci       Date:  1984-06       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.